KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Extracellular vesicles, including exosomes, mediate intercellular communication through RNA transfer.
• Argonaute 2 (Ago2), a core component of the RNA-induced silencing complex (RISC), is implicated in microRNA (miRNA) secretion.
• Aberrant KRAS signaling is common in colon cancer and may influence cellular communication pathways.

Purpose of the Study:

• To investigate the role of KRAS mutation in regulating Ago2 secretion in exosomes.
• To elucidate the molecular mechanisms by which KRAS affects Ago2 localization and exosomal release.
• To determine the impact of Ago2 exosomal sorting on miRNA levels.

Main Methods:

• Utilized isogenic colon cancer cell lines with and without KRAS mutations.
• Employed techniques to assess Ago2 localization to multivesicular endosomes (MVEs) and its secretion in exosomes.
• Investigated the effects of MEK and Akt inhibition on Ago2 trafficking and secretion.
• Analyzed Ago2 phosphorylation status and its impact on MVE interaction using mutant Ago2 constructs.

Main Results:

• Activating KRAS mutations inhibited Ago2 localization to MVEs and reduced its exosomal secretion.
• Inhibition of MEK signaling, but not Akt, reversed the KRAS-mediated inhibition of Ago2-MVE association and exosomal secretion.
• Phosphorylation of Ago2 at serine 387 was identified as a key event preventing MVE interaction and exosome release.
• Regulation of Ago2 exosomal sorting influenced the levels of specific candidate miRNAs within exosomes.

Conclusions:

• KRAS signaling, through MEK-dependent pathways, critically regulates Ago2 exosomal secretion in colon cancer cells.
• Ago2 phosphorylation at S387 is a key determinant of its sorting into exosomes.
• This pathway represents a novel mechanism controlling intercellular communication via miRNA-containing exosomes in cancer.